AntiDiabetic Cancer Research Results
AntiDiabetic, AntiDiabetic: Click to Expand ⟱
| Source: |
| Type: |
AntiDiabetic
|
Cerv, Cervical Cancer: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
TumCP↓, Apoptosis↑, RadioS↑, ChemoSen↑, *antiOx↑, *Inflam↓, *Bacteria↓, *AntiViral↑, *AntiDiabetic↑, *neuroP↑, AntiCan↑, TumCG↓, TumCI↓, TumCCA↑, cl‑PARP↑, selectivity↑, CycB/CCNB1↓, CDK1↓, p‑cDC2↓, p‑ERK↓, p‑p38↑, p‑JNK↑, MMP9↓, TIMP1↑, BioAv↓, BioAv↑, Half-Life↑,
| - |
in-vitro, |
CRC, |
DLD1 |
|
|
|
- |
in-vitro, |
Lung, |
A549 |
|
|
|
- |
in-vitro, |
Liver, |
HUH7 |
|
|
|
- |
in-vitro, |
Cerv, |
HeLa |
|
|
|
*antiOx↑, *AntiBio↑, *AntiDiabetic↑, *AntiCan↑, Dose↝, TumCP↓, ER Stress↑, Apoptosis↑, Bcl-2↓, BAX↑, Casp3↑, Casp9↑, Casp12↝, NF-kB↓, P53↑,
*Inflam↓, *antiOx↑, *neuroP↑, *AntiDiabetic↑, *Bacteria↓, AntiTum↑, CSCs↓, ROS↑, TumAuto↑, Apoptosis↑, ChemoSen↑, RadioS↑, BioAv↓, *cardioP↑, *ROS↓, *LDH↓, TumCP↓, TRAIL⇅, TumCMig↓, EMT↓, NF-kB↓, P53↑, Casp3↑, NOTCH↓, CSCs↓, angioG↓, VEGF↓, Ki-67↓, CD31/PECAM-1↓, TRAILR↑, MMP↓, BioAv↓, BioAv↑,
Showing Research Papers: 1 to 3 of 3
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 3
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
ROS↑, 1,
Mitochondria & Bioenergetics(tgid=3) ⓘ
MMP↓, 1,
Cell Death(tgid=5) ⓘ
Apoptosis↑, 3, BAX↑, 1, Bcl-2↓, 1, Casp12↝, 1, Casp3↑, 2, Casp9↑, 1, p‑JNK↑, 1, p‑p38↑, 1, TRAIL⇅, 1, TRAILR↑, 1,
Protein Folding & ER Stress(tgid=8) ⓘ
ER Stress↑, 1,
Autophagy & Lysosomes(tgid=9) ⓘ
TumAuto↑, 1,
DNA Damage & Repair(tgid=10) ⓘ
P53↑, 2, cl‑PARP↑, 1,
Cell Cycle & Senescence(tgid=11) ⓘ
CDK1↓, 1, CycB/CCNB1↓, 1, TumCCA↑, 1,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
p‑cDC2↓, 1, CSCs↓, 2, EMT↓, 1, p‑ERK↓, 1, NOTCH↓, 1, TumCG↓, 1,
Migration(tgid=13) ⓘ
CD31/PECAM-1↓, 1, Ki-67↓, 1, MMP9↓, 1, TIMP1↑, 1, TumCI↓, 1, TumCMig↓, 1, TumCP↓, 3,
Angiogenesis & Vasculature(tgid=14) ⓘ
angioG↓, 1, VEGF↓, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
NF-kB↓, 2,
Drug Metabolism & Resistance(tgid=21) ⓘ
BioAv↓, 3, BioAv↑, 2, ChemoSen↑, 2, Dose↝, 1, Half-Life↑, 1, RadioS↑, 2, selectivity↑, 1,
Clinical Biomarkers(tgid=22) ⓘ
Ki-67↓, 1,
Functional Outcomes(tgid=23) ⓘ
AntiCan↑, 1, AntiTum↑, 1,
Total Targets: 45
Pathway results for Effect on Normal Cells:
NA, unassigned(tgid=0) ⓘ
AntiBio↑, 1,
Redox & Oxidative Stress(tgid=1) ⓘ
antiOx↑, 3, ROS↓, 1,
Core Metabolism/Glycolysis(tgid=4) ⓘ
LDH↓, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
Inflam↓, 2,
Clinical Biomarkers(tgid=22) ⓘ
LDH↓, 1,
Functional Outcomes(tgid=23) ⓘ
AntiCan↑, 1, AntiDiabetic↑, 3, cardioP↑, 1, neuroP↑, 2,
Infection & Microbiome(tgid=24) ⓘ
AntiViral↑, 1, Bacteria↓, 2,
Total Targets: 12
Scientific Paper Hit Count for: AntiDiabetic, AntiDiabetic
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:29 Cells:% prod#:% Target#:1385 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid
Home Page